Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 65/100

Failure Rate

25.0%

1 terminated/withdrawn out of 4 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(66.7%)
Phase 3
1(33.3%)
3Total
N/A(2)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT02054013Not ApplicableCompleted

Prostatic Artery Embolization vs. Conventional Transurethral Prostatectomy in the Treatment of Benign Prostatic Hyperplasia

Role: lead

NCT01446822Not ApplicableCompleted

Safety Study of Bipolar Versus Monopolar Transurethral Resection of Bladder Tumors

Role: lead

NCT02304549Completed

A Prospective Investigation Using the Expired Breath Ethanol Test

Role: lead

NCT00464373Phase 3Terminated

Botulinum Toxin Type A for the Treatment of Male Chronic Pelvic Pain Syndrome

Role: lead

All 4 trials loaded